Laser Photonics Corporation, joined by its recently acquired subsidiary Control Micro Systems, Inc. (CMS), announced on December 5, 2024, the expansion of its tablet laser drilling technology development program. This initiative targets the pharmaceutical and medical technology market.
Tablet laser drilling is a proven method for creating sub-millimeter apertures in pharmaceutical tablets, crucial for osmotic pump time-release drug delivery systems. CMS's technology provides an automated, high-speed process capable of drilling up to 140,000 tablets per hour with orifices as small as 200 microns.
This R&D expansion, leveraging CMS expertise, aims to rapidly advance product offerings to meet the high demands of the pharmaceutical industry. The focus on precision and efficiency is transforming drug delivery systems, enhancing patient outcomes and streamlining production processes.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.